Lindsey Rolfe, See Remarks at Clovis Oncology, Inc. (CLVS), sold 21,635 shares at $7.97 ($172K) on 2021-02-02, disclosed to the SEC on 2021-02-03.
Open-market sale of $172k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 1,991 | $16K | 9.2% |
| 2 | $7.97 | 9,822 | $78K | 45.4% |
| 3 | $7.97 | 9,822 | $78K | 45.4% |
| Total | $7.97 avg | 21,635 | $172K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $8K | — | Filing → |